All attending UK organisations

UK companies attending BIO-Europe 2019 as part of the official delegation

(Click here to search profiles):

UK Pavilion:

Almac Group booth 4, MedCity & One Nucleus booth 5, BioPartner & UK delegation booth 7b,  National Institute of Health Research (NIHR) booth 7a, Health & Care Research Wales booth 8, SQN Clinical booth 9, Random42 Scientific Communication booth 13.

 Other UK Exhibitors:

Abzena booth 106, Barrington James booth 103, Black Swan Analysis booth 80, Brooks Life Sciences booth 182, CRA booth 16, Ergomed booth 63, Evaluate booth 75, Fujifilm Diosynth, GlobalData booth 19, Mallinckrodt Pharmaceuticals booth 18, Oxford Genetics booth 88, Pharma Intelligence booth 160, SEC Recruitment booth 151, SGS Vitrology booth 35, Symbiosis Pharmaceutical Services booth 11, Transpharmation booth 166, Valid Insight booth 71. 

UK Stand (Booth 7b):

Alacrita Holdings, Almac Discovery, ApconiX, Aptus Clinical, Arcinova, Cambridge Cancer Genomics, CEIDR, Clinical Network Services, Clinical Practice Research Datalink (CPRD), Curileum Discovery, Drug Discovery & Development Consultants, Health Innovation Research Alliance Northern Ireland (HIRANI), IDACO Consulting, ImmuPharma, Intract Pharma, Karma Oncology, LabGenius, LSX, Medherant, Mediwales, Mereo BioPharma Group, Mironid, Nanomerics, OBN, Oncimmune, Oppilotech, Oxford Biomedica, Oxstem, Pebmond Associates, PHASTAR, Pneumagen, Scottish Development International, Shield Therapeutics, Sphere Fluidics, Therakind, UK BioIndustry Association (BIA).

Other UK companies associated with the delegation*:

Abzena, Albumedix, ALSA Ventures, AMR Centre, CIMYM BioSciences, Circassia, CLINICAL ACCELERATOR, Crescendo Biologics, C4X Discovery, Diurnal, Domainex, e Therapeutics, Fusion Antibodies, IAG, Invest Northern Ireland, Isogenica, J A Kemp, MGB Biopharma, Phoremost, ProAxsis, ProImmune, Sareum, Sekisui, Selcia, Silence Therapuetics, Sygnature Discovery, SYNthesis Research, Tissue Solutions, UCB, Vaccitech, Worldwide Clinical Trials.      

UK Presenting companies:

will be listed here

All attending UK companies:

3M United Kingdom, 4BIO, 4D pharma, AbbVie, Abcam, Abingworth, Abzena, Achilles Therapeutics, Advanz Pharma, Alacrita Holdings, Albumedix, Almac Discovery, Almac Group, Alpha Blue Ocean, ALSA Ventures, Amplity Health, AMR Centre, Antev, ApconiX, Apex Healthcare Consulting, Aptus Clinical, Arcinova, Arctoris, Arix Bioscience, ARJUNA Therapeutics, Artios Pharma, Astellas Pharma, Aston University, AstraZeneca, Atlantic Healthcare, AUTOLUS, Barrington James, Bioarchitect, Biogen, BioPartner UK, Biopharma Group, Bird & Bird, bit bio, BiVictriX Therapeutics, Black Belt Tx, Black Swan Analysis, Bristows, C4X Discovery, Cambridge Cancer Genomics, Cancer Research UK, Cardiff University, Carmichael Fisher, CEIDR, Cell Medica, Censo Biotechnologies, Centauri Therapetics, Champions Oncology, Charles River Associates, Charles River Laboratories, Chiesi, Chugai Pharmaceutical, CIMYM BioSciences, Circassia, Citigate Dewe Rogerson, Clarivate Analytics, CLINICAL ACCELERATOR, Clinical Network Services (UK), Clinical Practice Research Datalink (CPRD), Clinigen, CN Bio Innovations, Concept Life Sciences, Consilient Health, CoSec Consulting, Coulter Partners, Covance, Crescendo Biologics, Crescita Therapeutics, Curadev Pharma, Curileum Discovery, Dechert, Decision Resources Group, Dementia Discovery Fund, Destiny Pharma, Discovery Park, Diurnal, Domainex, Drug Discovery & Development Consultants, Drug Discovery Unit, University of Dundee, DuPont, Durham University, e Therapeutics, EBD Group, Edinburgh Innovations, Eisai Europe, Elasmogen, Eli Lilly and Company, emotive, Enterprise Therapeutics, Epidarex Capital, Evaluate, Evercore, Evox Therapeutics, Exscientia, F2G, Femtogenix, Freeline Therapeutics, F-Star Biotechnology, FUJIFILM Diosynth Biotechnologies, Ergomed, Fusion Antibodies, Galbraith Wight, Gill Jennings & Every, Global Innovation Forum, GlobalData, Gowling WLG (UK), GSK Consumer Healthcare, GSK Pharmaceuticals, HC Pharma Consultancy, Health and Care Research Wales, Health Innovation Research Alliance Northern Ireland (HIRANI), Healx, Hobson Prior, Horizon Discovery, HPCI Media, IAG, IDACO Consulting, IGEM Therapeutics, Iksuda Therapeutics, Immunocore, ImmuPharma, Imperial College London, In Vivo - Pharma Intelligence, Inceptua, Informa, IN-PART, Intract Pharma, Invest Northern Ireland, IONTAS, IQVIA, Isogenica, J A Kemp, Jefferies International, Johnson & Johnson, KaNDy Therapeutics, Karma Oncology, Korn Ferry, Kx Advisors, Kymab, Kyowa Kirin, LabGenius, Lacerta Bio, Leaf Expression Systems, LIfT BioSciences, Locate Bio, Locust Walk, LONZA, LSX, Macrophage Pharma, Mallinckrodt Pharmaceuticals, McDermott Will & Emery, MedCity, Medherant, Mediwales, MedPharm, Merck Healthcare, Merck Life Science, Mereo BioPharma Group, MGB Biopharma, Midatech Pharma, MIP Diagnostics, Mironid, Mission Therapeutics, Mitsubishi Tanabe Pharma Corporation, Mogrify, Morgan Prestwich, MSD, MUNDIPHARMA, Mundipharma International, mycoBiologics, Nanomerics, National Institute of Health Research (NIHR), neurocentrx pharma, NeuroLight, Newcastle University, Norgine BV, Norgine Ventures, OBN UK, Oncimmune, Ondra, One Nucleus, Ono Pharma, Oppilotech, Orbit Discovery, Otsuka Pharmaceutical Company, Oval Medical Technologies, Owlstone Medical, Oxford Biomedica, Oxford BioTherapeutics, Oxford Brookes University, OXGENE, OxStem, Pebmond Assciociates, PeproTech EC, Pfizer Inc, PharmaCircle, Pharmalicensing, PharmaVentures, PHASTAR, Phoremost, Piramal Pharma Solutions, Plexsus Consulting, Pneumagen, Pontifax, PPD, Premier Research, Prescient Healthcare Group, ProAxsis, Procarta Biosystems, ProClinical, ProImmune, Prokarium, Q2 Solutions, Quadram Institute, Quay Pharmaceuticals, Queen Mary Innovation, Queens University Belfast, Random42 Scientific Communication, RBC Capital Markets, Redx Pharma, ReNeuron, Rephine, Results Healthcare, ReViral, Rexgenero, RSA Consulting, Sachs Associates, Sage Group, Samedan, Sareum, Sartorius Stedim Biotech, SBA, Scancell, Scius Communications, Scottish Development International, SEC Recruitment, Sekisui, Selcia, SGS, Shanghai Medicilon, Shield Therapeutics, Shift Bioscience, Shionogi & Co, Silence Therapeutics, Simbec Orion, Simcere Pharmaceutical Group / Simcere UK, SLA Pharma, SmartAnalyst, SOBI, Sojournix, Inc, Sosei Heptares, Sphere Fluidics, SQN Clinical, Stemmatters, Storm Therapeutics, Summit Therapeutics, SV Health Managers, Swedish Orphan Biovitrum, Sygnature Discovery, Symbiosis Pharmaceutical Services, Syneos Health, SYNthesis Research, Teijin Pharma, The Fulford Group, The Institute of Cancer Research, Theolytics, Therakind, Thermo Fisher Scientific, Tissue Solutions, Topivert Pharma, Torreya, tranScrip, Transpharmation  / InterVivo Solutions, Treehill Partners, Ubiquigent, UCB, UCB Ventures, UCL Business, UK BioIndustry Association (BIA), University of Bradford, University of Leeds, University of Nottingham, University of Warwick, Vaccitech, Valid Insight, Valo Therapeutics, Venari Partners, Vernalis R&D, Viramal, Virdis Group, Warwick Ventures, Worldwide Clinical Trials, Wren Therapeutics, WuXi AppTec Group, Xcenda GmbH, Ximbio (Cancer Research UK), Yakumed.

Join them here!